Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

KOSDAQ/049960 stock hub

KOSDAQ/049960 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/049960is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
112.6B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/049960
In the news

Latest news · KOSDAQ/049960

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E11.1
P25 n/aP50 n/aP75 n/a
ROE7.9
P25 n/aP50 n/aP75 n/a
ROIC18.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/049960 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
233
Groups with data
11
Currency
KRW
Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
South Korea
Country code
KR
Employees
101
Enterprise value
KRW 19.9B
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
KRW 112.6B
Price
KRW 16,450
Price currency
KRW
Rev Per Employee
525,996,767.03x
Sic
2836
Symbol
kosdaq/049960
Website
https://www.cellbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
8.99%
EV Earnings
1.97x
EV/EBIT
2.52x
EV/EBITDA
1.73x
EV/FCF
2.49x
EV/Sales
0.38x
FCF yield
7.11%
P/B ratio
0.86x
P/E ratio
11.12x
P/S ratio
2.12x
PE Ratio10 Y
27.6x
PE Ratio3 Y
48.34x
PE Ratio5 Y
36.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
14.9%
EBITDA Margin
21.7%
FCF margin
15.07%
Gross margin
72.2%
Gross Profit
KRW 38.4B
Gross Profit Growth
7.11%
Gross Profit Growth Q
21.31%
Gross Profit Growth3 Y
0.6%
Gross Profit Growth5 Y
2.28%
Net Income
KRW 10.1B
Net Income Growth
-33.06%
Net Income Growth Q
-35.96%
Net Income Growth3 Y
6.93%
Net Income Growth5 Y
25.99%
Pretax Margin
21.18%
Profit Margin
19.06%
Profit Per Employee
KRW 100.2M
ROA
3.71
Roa5y
3.15
ROCE
6.01
ROE
7.92
Roe5y
8.84
ROIC
18.32
Roic5y
12.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr10y
-10.05%
Cagr15y
10.84%
Cagr1y
31.99%
Cagr20y
9.81%
Cagr3y
9.85%
Cagr5y
0.27%
Div CAGR10
0.87%
Div CAGR3
10.06%
Div CAGR5
5.92%
EPS Growth
-33.08
EPS Growth Q
-36
EPS Growth3 Y
7.19
EPS Growth5 Y
26.89
FCF Growth
-55.87%
FCF Growth Q
-8.9%
FCF Growth3 Y
-8.49%
FCF Growth5 Y
4.3%
OCF Growth
-42.34%
OCF Growth Q
-10.9%
OCF Growth10 Y
-4.84%
OCF Growth3 Y
-4.65%
OCF Growth5 Y
3.04%
Revenue Growth
6.44x
Revenue Growth Q
20.38x
Revenue Growth3 Y
1.69x
Revenue Growth5 Y
3.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
KRW 0.4
Assets
KRW 136.6B
Cash
KRW 93.1B
Current Assets
KRW 103.7B
Current Liabilities
KRW 4.9B
Debt
KRW 425.4M
Debt EBITDA
KRW 0.04
Debt Equity
KRW 0
Debt FCF
KRW 0.05
Equity
KRW 131.6B
Interest Coverage
242.8
Liabilities
KRW 4.9B
Long Term Assets
KRW 32.9B
Long Term Liabilities
KRW 75.3M
Net Cash
KRW 92.6B
Net Cash By Market Cap
KRW 82.28
Net Cash Growth
7.17%
Net Debt EBITDA
KRW -8.04
Net Debt Equity
KRW -0.7
Net Debt FCF
KRW -11.57
Tangible Book Value
KRW 130.5B
Tangible Book Value Per Share
KRW 19,039
WACC
6.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
21.34
Inventory Turnover
3.35
Net Working Capital
KRW 6.1B
Quick ratio
20.19
Working Capital
KRW 98.9B
Working Capital Turnover
KRW 0.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.02%
Dividend Growth
33.33%
Dividend Growth Years
1%
Dividend per share
KRW 600
Dividend Years
19
Dividend Yield
3.65%
Ex Div Date
2025-12-29
Last Dividend
KRW 600
Payout Frequency
Annual
Payout Ratio
30.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-65.34%
1Y total return
31.96%
200-day SMA
13,468.7
3Y total return
32.57%
50-day SMA
14,870.8
50-day SMA vs 200-day SMA
50over200
5Y total return
1.36%
All Time High
73,300
All Time High Change
-77.56%
All Time High Date
2015-02-24
All Time Low
1,036.2
All Time Low Change
1,487.46%
All Time Low Date
2003-01-29
ATR
512.3
Beta
0.42
Beta1y
0.35
Beta2y
0.42
Ch YTD
25.48
High
16,480
High52
16,710
High52 Date
2026-04-17
High52ch
-1.56%
Low
15,610
Low52
11,350
Low52 Date
2025-11-05
Low52ch
44.93%
Ma50ch
10.62%
Price vs 200-day SMA
22.14%
RSI
65.26
RSI Monthly
65.86
RSI Weekly
71.66
Sharpe ratio
0.96x
Sortino ratio
1.91
Total Return
3.76%
Tr YTD
25.48
Tr15y
368.01%
Tr1m
13.84%
Tr1w
3.85%
Tr3m
23.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
KRW 7.9B
Operating Income Growth
16.45
Operating Income Growth Q
171
Operating Income Growth3 Y
9.36
Operating Income Growth5 Y
16.63
Operating margin
14.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
4,423,287%
Net Borrowing
-612,734,440
Shares Insiders
35.37%
Shares Institutions
8.75%
Shares Out
6,843,900
Shares Qo Q
0.12%
Shares Yo Y
0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
KRW 8B
Average Volume
26,627.85x
Bv Per Share
19,210.9
CAPEX
KRW -3.1B
Ch10y
-73.38
Ch15y
240.9
Ch1m
13.84
Ch1w
3.85
Ch1y
27.62
Ch20y
312.3
Ch3m
23.41
Ch3y
19.2
Ch5y
-14.1
Ch6m
40.12
Change
3.72%
Change From Open
3.72
Close
15,860
Days Gap
0
Depreciation Amortization
3,614,114,000
Dollar Volume
689,748,500
Earnings Date
2026-05-12
EBIT
KRW 7.9B
EBITDA
KRW 11.5B
EPS
KRW 1,479
F Score
6
FCF
KRW 8B
FCF EV Yield
40.13x
FCF Per Share
KRW 1,170
Financing CF
-3,692,489,440
Fiscal Year End
December
Founded
1,995
Graham Number
25284.22105
Graham Upside
53.7
Income Tax
KRW 1.1B
Investing CF
4,590,244,850
Is Primary Listing
1
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Lynch Fair Value
KRW 36,975
Lynch Upside
124.8
Ma150
13,591.7
Ma150ch
21.03%
Ma20
15,842
Ma20ch
3.84%
Net CF
12,382,407,800
Next Earnings Date
2026-05-12
Open
15,860
P FCF Ratio
14.06
P OCF Ratio
10.13
Payment Date
2026-04-07
Position In Range
96.55
Ppne
30,459,528,400
Price Date
2026-05-08
Price EBITDA
KRW 9.77
Ptbv Ratio
0.86
Relative Volume
1.57x
Revenue
53,125,673,470x
Tax By Revenue
2.12x
Tax Rate
10.03%
Tr20y
550.11%
Tr6m
44.89%
Volume
41,930
Z Score
13.74
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KOSDAQ/049960 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.6%
$600 annual per share
Payout ratio
+30.4%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+5.9%
1 consecutive years of growth
Total shareholder yield
+3.6%
Next ex-dividend date: 2025-12-29
Performance

KOSDAQ/049960 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+32.0%
S&P 500 1Y: n/a
3Y total return
+32.6%
S&P 500 3Y: n/a
5Y total return
+1.4%
S&P 500 5Y: n/a
10Y total return
-65.3%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/049960?

Insider, institutional, and short-interest positioning.

Institutional ownership
+8.7%
Share of float held by funds and institutions
Insider ownership
+35.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

KOSDAQ/049960 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
65.3
Neutral momentum band
Price vs 200-day MA
+22.1%
50/200-day relationship not available
Beta (5Y)
0.42
Less volatile than the market
Sharpe ratio
0.96
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/049960

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/049960 stock rating?

kosdaq/049960 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/049960 analysis?

The full report lives at /stocks/kosdaq/049960/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/049960?

The latest report frames kosdaq/049960 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/049960 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.